for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CureVac BV

5CV.DE

Latest Trade

65.99EUR

Change

-3.41(-4.91%)

Volume

186,487

Today's Range

64.46

 - 

70.85

52 Week Range

37.15

 - 

120.82

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
69.40
Open
69.04
Volume
186,487
3M AVG Volume
16.61
Today's High
70.85
Today's Low
64.46
52 Week High
120.82
52 Week Low
37.15
Shares Out (MIL)
191.91
Market Cap (MIL)
15,804.27
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

EMA Starts Rolling Review Of Curevac's COVID-19 Vaccine

Curevac And UK Government To Collaborate On Development Of Vaccines Against SARS-Cov-2 Variants

Curevac Announces Full Exercise Of Underwriters' Option To Purchase Additional Common Shares

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About CureVac BV

CureVac AG is a Germany-based biotechnology company. The Company is engaged in the therapeutic development of messenger Ribonucleic Acid (mRNA) and RNA-based vaccines. CureVac AG focuses on developing vaccines for infectious diseases and drugs to treat cancer and rare diseases. The Company's pipeline focuses on three areas: cancer immunotherapy, prophylactic vaccines, and protein-based therapies.

Industry

Biotechnology & Drugs

Contact Info

Friedrich-Miescher-Str. 15

72076

Germany

+49.7071.98830

Key Stats

2.60 mean rating - 5 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2020(E)

0.1K
EPS (EUR)

2020(E)

-1.934
Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
16.15
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
4.03
LT Debt To Equity (MRQ)
3.64
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up